Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Crowe

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Journal of Gerontological Nursing|April 25, 2000
Use of the Iowa Self-Assessment Inventory with older hospitalized patientsC Hegamin-Younger, M L Piven, K C Buckwalter, et al.
Virus Research|April 1, 1994
An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccinesB R Murphy, S L Hall, A B Kulkarni, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 1992
Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivityC F Barbas, J E Crowe, D Cababa, et al.
Journal of Virology|August 1, 1997
The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L proteinK Juhasz, S S Whitehead, P T Bui, et al.
Radiology|December 1, 1992
Shifting pneumothorax after heart-lung transplantationC E Engeler, P N Olson, C M Engeler, et al.
American Journal of Diseases of Children (1960)|January 1, 1981
Radiological case of the monthT E Sumner, J E Crowe, A Klein, et al.
Virology|January 8, 1999
Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoproteinJ E Crowe, C Y Firestone, R Crim, et al.
Mbio|October 15, 2015
A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodiesE N Gallichotte, D G Widman, B L Yount, et al.
Bone Marrow Transplantation|June 26, 2010
Regulatory T cell expression of CLA or α(4)β(7) and skin or gut acute GVHD outcomesB G Engelhardt, M Jagasia, B N Savani, et al.
The Journal of Infectious Diseases|September 30, 2000
Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancyP F Wright, R A Karron, R B Belshe, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Journal of Gerontological Nursing|April 25, 2000
Use of the Iowa Self-Assessment Inventory with older hospitalized patientsC Hegamin-Younger, M L Piven, K C Buckwalter, et al.
Virus Research|April 1, 1994
An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccinesB R Murphy, S L Hall, A B Kulkarni, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 1992
Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivityC F Barbas, J E Crowe, D Cababa, et al.
Journal of Virology|August 1, 1997
The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L proteinK Juhasz, S S Whitehead, P T Bui, et al.
Radiology|December 1, 1992
Shifting pneumothorax after heart-lung transplantationC E Engeler, P N Olson, C M Engeler, et al.
American Journal of Diseases of Children (1960)|January 1, 1981
Radiological case of the monthT E Sumner, J E Crowe, A Klein, et al.
Virology|January 8, 1999
Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoproteinJ E Crowe, C Y Firestone, R Crim, et al.
Mbio|October 15, 2015
A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodiesE N Gallichotte, D G Widman, B L Yount, et al.
Bone Marrow Transplantation|June 26, 2010
Regulatory T cell expression of CLA or α(4)β(7) and skin or gut acute GVHD outcomesB G Engelhardt, M Jagasia, B N Savani, et al.
The Journal of Infectious Diseases|September 30, 2000
Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancyP F Wright, R A Karron, R B Belshe, et al.
Pageof 7